StockData
Gossamer Bio, Inc. logo

Gossamer Bio, Inc. (GOSS) stock

GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$11.04+0.06 (+0.55%)

Close on Nov 17, 2026Market cap $5.40BP/E –Yield –

Gossamer Bio cash

Cash and short-term investments held at the end of each period.

Gossamer Bio's cash was $57.03M at Jun 30, 2026. For fiscal 2025 it was $136.93M, down 53.5% from the year before. The highest annual figure on record is $513.19M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$136.93M-53.5%
FY2024Dec 31, 2024$294.52M-0.6%
FY2023Dec 31, 2023$296.43M+15.9%
FY2022Dec 31, 2022$255.68M-21.4%
FY2021Dec 31, 2021$325.28M-36.6%
FY2020Dec 31, 2020$513.19M+27.7%
FY2019Dec 31, 2019$401.83M+75.6%
FY2018Dec 31, 2018$228.86M+72553.3%
FY2017Dec 31, 2017$315.00K+425.0%
FY2016Dec 31, 2016$60.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$57.03M-73.2%
Q1 FY2026Mar 31, 2026$99.22M-61.5%
Q4 FY2025Dec 31, 2025$136.93M-53.5%
Q3 FY2025Sep 30, 2025$180.22M-44.9%
Q2 FY2025Jun 30, 2025$212.92M-39.9%
Q1 FY2025Mar 31, 2025$257.93M+5.5%
Q4 FY2024Dec 31, 2024$294.52M-0.6%
Q3 FY2024Sep 30, 2024$327.03M-0.6%
Q2 FY2024Jun 30, 2024$354.49M+118.6%
Q1 FY2024Mar 31, 2024$244.39M+21.1%
Q4 FY2023Dec 31, 2023$296.43M+15.9%
Q3 FY2023Sep 30, 2023$328.89M+8.1%
Q2 FY2023Jun 30, 2023$162.13M-27.0%
Q1 FY2023Mar 31, 2023$201.86M-25.7%
Q4 FY2022Dec 31, 2022$255.68M-21.4%
Q3 FY2022Sep 30, 2022$304.38M-16.9%
Q2 FY2022Jun 30, 2022$222.16M-45.3%
Q1 FY2022Mar 31, 2022$271.69M-40.1%
Q4 FY2021Dec 31, 2021$325.28M-36.6%
Q3 FY2021Sep 30, 2021$366.08M-34.1%
Q2 FY2021Jun 30, 2021$406.49M-32.3%
Q1 FY2021Mar 31, 2021$453.62M+31.0%
Q4 FY2020Dec 31, 2020$513.19M+27.7%
Q3 FY2020Sep 30, 2020$555.38M+24.4%
Q2 FY2020Jun 30, 2020$600.36M+29.4%
Q1 FY2020Mar 31, 2020$346.17M-28.1%
Q4 FY2019Dec 31, 2019$401.83M+75.6%
Q3 FY2019Sep 30, 2019$446.47M+216.0%
Q2 FY2019Jun 30, 2019$464.00M+1334.5%
Q1 FY2019Mar 31, 2019$481.22M+507.8%
Q4 FY2018Dec 31, 2018$228.86M+72553.3%
Q3 FY2018Sep 30, 2018$141.27M+235345.0%
Q2 FY2018Jun 30, 2018$32.35M–
Q1 FY2018Mar 31, 2018$79.18M–
Q4 FY2017Dec 31, 2017$315.00K–
Q4 FY2016Dec 31, 2016$60.00K–

More Gossamer Bio figures

See a number that looks wrong?